Norway: Responsibility for supervision of medical devices will be transferred from Norwegian Directorate of Health to the Norwegian Medicines Agency

12

Jun 2017

The Norwegian Directorate of Health is a professional and supervisory authority for medical devices in Norway; it supervises products, manufacturers and other traders, as well as technical control bodies.

The transfer of responsibilities is in connection to newly adopted EU regulation for medical devices.

See full story in Norwegian here

Subscribe to our biweekly newsletter not to miss important reimbursement information.

Tags

The latest related news

23

Feb 2022

On January 24, 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than March 01, 2022. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added medical biochemistry, medical microbiology, immunology and transfusiology, and clinical pharmacology areas.

Read more

02

Feb 2022

The "New Method" is currently developing criteria for which methods other than drugs shall be prioritized for assessment within the framework at the national or local levels. On January 17, 2022, the project status was presented at the Ordering Forum for "New Method." It was reported that the project would require more resources and time than initially thought.

Read more

03

Dec 2021

On November 23, 2021, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than January 01, 2021. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added in medical biochemistry, immunology and transfusiology, and clinical pharmacology areas.

Read more

29

Oct 2021

On September 27, 2021, the Decision Forum for "New Methods" decided not to introduce bronchial thermoplasty as a routine treatment of patients with severe asthma. The method should only be used within clinical trials.

Read more

26

Oct 2021

On September 23, 2021, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than November 01, 2021. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty-nine new codes were added in medical biochemistry, clinical pharmacology, and medical microbiology areas.

Read more